Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
Ingrid GarajovàFabio GelsominoMassimiliano SalatiAnna MingozziMarianna PeroniStefania De LorenzoAlessandro GranitoFrancesco TovoliFrancesco LeonardiPublished in: Life (Basel, Switzerland) (2023)
Not all patients seem to benefit from second-line chemotherapy. To improve therapeutic decisions, performance status and disease control with first-line chemotherapy should lead to the decision on the usefulness of second-line treatments in advanced ICC patients.